When should patients with neutropenia receive antibiotics for infection prevention? Which agents and regimens should be used? Should antibiotics be used in patients with extreme non-chemotherapy-induced neutropenia who are not more prone to infections than the general population?
What are the most important advances in the diagnosis, treatment, and prevention of tropical diseases in the past years? Can we expect any breakthrough in the treatment of neglected tropical diseases?
During the COVID-19 pandemic, many countries experienced difficulties in implementing vaccination programs and other infectious disease control measures. This affected the epidemiology of some diseases, with increase in the global number of malaria cases being an example. How significant are these epidemiologic changes for clinical practice?
What would you advise to your inexperienced colleagues faced with a febrile patient returning from tropical countries? What clues from the history and physical examination findings may suggest a potentially life-threatening infection in such patients?
What key points should physicians practicing in nonendemic areas keep in mind when treating patients returning from a tropical country with fever?
What management strategy is currently recommended for patients with dengue fever?
What are the primary principles of differential diagnosis in adults who have traveled to tropical countries and present with fever and rash upon return?
As far as you are in a position to judge, in what ways was the response to COVID-19 different in South Asian countries compared with the rest of the world?
If you were to name the 3 most important recent advances in infectious diseases in South Asia that are relevant for everyday practice, what would they be?
You have extensive experience in managing COVID-19. If you were to advise colleagues without such experience, what would you tell them to pay special attention to?
English
Polski
Español
українська